May 4, 2026

Hologic, Inc. (HOLX) Stock Analysis: Exploring the Healthcare Giant’s Strong Position with Limited Upside

Hologic, Inc. (NASDAQ: HOLX), a prominent player in the healthcare sector, particularly in medical instruments and supplies, boasts a robust market capitalization of $16.97 billion. With its headquarters in Marlborough,..

Roivant Sciences Ltd. (ROIV) Stock Analysis: A 28% Upside in Biotech Innovation

Roivant Sciences Ltd. (NASDAQ: ROIV), a prominent player in the biotechnology sector, is capturing investor attention with a potential upside of 28.16%, according to the latest analyst ratings. As a..

Incyte Corporation (INCY) Stock Analysis: Unveiling a 12% Potential Upside in the Biotech Sector

Incyte Corporation (NASDAQ: INCY), a prominent player in the biotechnology sector, presents an intriguing investment opportunity with its robust pipeline and a notable potential upside of nearly 12%. As the..

Chemed Corp (CHE) Stock Analysis: Navigating Healthcare Growth with a 5.77% Upside Potential

Chemed Corp (NYSE: CHE), a stalwart in the healthcare sector, has carved a notable niche within the medical care facilities industry. With a market capitalization of $5.6 billion, the company..

Medpace Holdings, Inc. (MEDP) Stock Analysis: Examining the Strategic Healthcare Player with a 26.5% Revenue Growth

Medpace Holdings, Inc. (NASDAQ: MEDP) stands out as a formidable player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $11.92 billion, this..

Royalty Pharma plc (RPRX): Analyst Consensus Signals Potential Upside Amid Biotech Growth

Royalty Pharma plc (NASDAQ: RPRX) stands as a prominent player in the healthcare sector, specifically within the biotechnology industry. With a market capitalization of $29.33 billion, this New York-based company..

Medtronic plc (MDT) Stock Analysis: Uncovering a 35% Upside Potential

Medtronic plc (MDT), a giant in the medical devices industry, commands a market capitalization of $102.71 billion and stands as a vital player in the healthcare sector. Headquartered in Galway,..

AptarGroup, Inc. (ATR) Stock Analysis: Exploring a 37% Potential Upside

AptarGroup, Inc. (NYSE: ATR) has long been a noteworthy player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of $7.66 billion, the..

Viatris Inc. (VTRS) Stock Analysis: Is This Healthcare Giant Poised for a 4.54% Upside?

Viatris Inc. (VTRS), a formidable player in the healthcare sector, has captured investor attention with its diverse portfolio and strategic global presence. With a market capitalization of $17.51 billion, Viatris..

DexCom, Inc. (DXCM) Stock Analysis: Unveiling a 36% Upside Potential Amidst Robust Revenue Growth

For investors focusing on the healthcare sector, DexCom, Inc. (NASDAQ: DXCM) presents an intriguing opportunity with its significant upside potential and robust revenue growth. Specializing in continuous glucose monitoring (CGM)..

Penumbra, Inc. (PEN) Stock Analysis: A 12.44% Potential Upside in the Thriving Medical Devices Sector

Penumbra, Inc. (NYSE: PEN), a prominent player in the healthcare sector, specifically in the medical devices industry, showcases significant growth potential for investors eyeing the burgeoning market for innovative medical..

Avantor, Inc. (AVTR) Stock Analysis: Navigating a Complex Landscape with a 24.66% Potential Upside

Avantor, Inc. (AVTR), a key player in the healthcare sector, stands at an intriguing crossroads for investors. With a market capitalization of $5.43 billion, Avantor is a significant entity within..

Natera, Inc. (NTRA) Stock Analysis: A 24.47% Potential Upside with Strong Buy Ratings

Investors eyeing opportunities in the healthcare sector may find Natera, Inc. (NASDAQ: NTRA) an intriguing option, with a market cap of $29.6 billion and a robust portfolio in the diagnostics..

Henry Schein, Inc. (HSIC) Stock Analysis: Assessing a 22% Upside Potential in the Healthcare Sector

Henry Schein, Inc. (NASDAQ: HSIC) stands as a pivotal player in the healthcare sector, specifically within the medical distribution industry. With a robust market capitalization of $8.48 billion, the company..

DaVita Inc. (DVA) Stock Analysis: Navigating a 0.04% Potential Upside in the Healthcare Sector

DaVita Inc. (NYSE: DVA), a prominent player in the healthcare sector, is primarily focused on providing kidney dialysis services across the United States. With a market cap of $10 billion,..

Encompass Health Corporation (EHC) Stock Analysis: Unveiling a 31.95% Potential Upside

Encompass Health Corporation (NYSE: EHC), a prominent player in the healthcare sector, specifically within the medical care facilities industry, is capturing investor attention with its impressive market performance and growth..

Bristol-Myers Squibb (BMY) Stock Analysis: Unpacking the 8.76% Potential Upside

For investors with a keen eye on the healthcare sector, Bristol-Myers Squibb Company (NYSE: BMY) presents a compelling opportunity. With a market capitalization of $118.87 billion, this biopharmaceutical giant continues..

BioMarin Pharmaceutical (BMRN) Stock Analysis: Uncovering a 66.79% Upside Potential

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) stands as a formidable player in the biotechnology sector, known for its dedication to developing therapies for rare and life-threatening conditions. With a market capitalization..

Fresenius Medical Care AG (FMS) Stock Analysis: Unlocking a 21.95% Potential Upside in the Healthcare Sector

Fresenius Medical Care AG (NYSE: FMS) stands as a prominent player in the healthcare sector, particularly within the medical care facilities industry. Headquartered in Bad Homburg, Germany, the company specializes..

ResMed Inc. (RMD) Stock Analysis: Exploring a 31.99% Potential Upside in the Healthcare Sector

ResMed Inc. (RMD), a prominent player in the healthcare sector, has positioned itself as a leader in the medical instruments and supplies industry. With a market capitalization of $29.87 billion,..

Search

Funds

May 4, 2026

Search

Funds

May 4, 2026

FTSE 100

Funds